派博傳思國(guó)際中心

標(biāo)題: Titlebook: Normative Health Economics; A New Pragmatic Appr Sardar M. N. Islam,Christine Suet Yee Mak Book 2006 Palgrave Macmillan, a division of Macm [打印本頁(yè)]

作者: 習(xí)慣    時(shí)間: 2025-3-21 18:25
書(shū)目名稱Normative Health Economics影響因子(影響力)




書(shū)目名稱Normative Health Economics影響因子(影響力)學(xué)科排名




書(shū)目名稱Normative Health Economics網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Normative Health Economics網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Normative Health Economics被引頻次




書(shū)目名稱Normative Health Economics被引頻次學(xué)科排名




書(shū)目名稱Normative Health Economics年度引用




書(shū)目名稱Normative Health Economics年度引用學(xué)科排名




書(shū)目名稱Normative Health Economics讀者反饋




書(shū)目名稱Normative Health Economics讀者反饋學(xué)科排名





作者: 愛(ài)管閑事    時(shí)間: 2025-3-21 23:55
PBS Planning: Modelling and Implications,pter 3 to sub-sector planning of PBS (we call it PBS planning), and discuss the implications of PBS sub-sector planning in selecting a set of medications for PBS listing that can maximise health and social welfare of the society.
作者: Definitive    時(shí)間: 2025-3-22 01:11
Introduction, substantially based on the principles of normative economics or welfare economics, a discipline concerned with finding a normative framework to make social choices regarding the socially desirable state of the economy.
作者: 貴族    時(shí)間: 2025-3-22 05:36

作者: TAIN    時(shí)間: 2025-3-22 09:09

作者: confederacy    時(shí)間: 2025-3-22 13:58
Book 2006This book modifies the existing economic theory of health analysis by integrating the issues and principles of moral philosophy in an extended framework. It also develops some operational mathematical models to show how this framework can be applied to health economics and policy evaluation.
作者: Kidnap    時(shí)間: 2025-3-22 20:34

作者: 有說(shuō)服力    時(shí)間: 2025-3-22 21:23

作者: 評(píng)論性    時(shí)間: 2025-3-23 02:40
Overview: This book modifies the existing economic theory of health analysis by integrating the issues and principles of moral philosophy in an extended framework. It also develops some operational mathematical models to show how this framework can be applied to health economics and policy evaluation.978-0-230-28905-5
作者: 廚師    時(shí)間: 2025-3-23 05:51
New3 Cost Benefit Analysis of PBS Medications,t Advisory Committee (PBAC) submission guidelines, the standard approach of financial cost benefit analysis and the new. cost benefit analysis under the normative social choice approach of new. welfare economics.
作者: Ossification    時(shí)間: 2025-3-23 11:50
Summary and Conclusion,benefit analysis, the application of this new approach to the Pharmaceutical Benefit Scheme (PBS) in Australia, and the implications of the findings for economic evaluation and normative economics with a special emphasis on the implications for health economics.
作者: 哺乳動(dòng)物    時(shí)間: 2025-3-23 15:14
Cost and Benefit Estimates,In this chapter, we discuss the general principles and methods of estimating costs and benefits of six medications (namely Atorvastatin, Clopidogrel, Pioglitazone, Letrozole, Fluticasone/ Salmeterol and Tiotropium) while the detailed estimates of the costs and benefits and their analysis will be provided in the next chapter.
作者: characteristic    時(shí)間: 2025-3-23 18:30

作者: 嚴(yán)厲批評(píng)    時(shí)間: 2025-3-24 00:26

作者: 空中    時(shí)間: 2025-3-24 03:22
New3 Cost Benefit Analysis,to be useful and meaningful, certain adjustments are needed- Omission of extra-welfaristic elements in social costs and social benefits, inappropriate measures of benefits, difficulties in measuring benefits and a lack of proper integration of cost benefit analysis methods of health programs with th
作者: 灌輸    時(shí)間: 2025-3-24 10:24
Economic Evaluation: The Case of the Australian PBS,ing, pharmaceutical expenditure attracts the attention of government regulators, the public or private fund holders because absolute expenditure continues to grow; pharmaceuticals are perceived more as products than as services; and there is a growing concern that new biotechnology and biogenomic pr
作者: 加劇    時(shí)間: 2025-3-24 14:01
New3 Cost Benefit Analysis of PBS Medications,t Advisory Committee (PBAC) submission guidelines, the standard approach of financial cost benefit analysis and the new. cost benefit analysis under the normative social choice approach of new. welfare economics.
作者: Concrete    時(shí)間: 2025-3-24 17:39

作者: burnish    時(shí)間: 2025-3-24 18:59

作者: DAMN    時(shí)間: 2025-3-24 23:49

作者: Biguanides    時(shí)間: 2025-3-25 07:21
New3 Cost Benefit Analysis, which are measured adequately and appropriately. Extra-welfaristic considerations (such as equity, freedom, and so on) in ethics, incorporated in the integrated operational framework and methods of cost benefit analysis, can then be applied in the evaluation.
作者: 使長(zhǎng)胖    時(shí)間: 2025-3-25 10:14

作者: drusen    時(shí)間: 2025-3-25 15:01
6樓
作者: Physiatrist    時(shí)間: 2025-3-25 15:55
6樓
作者: intelligible    時(shí)間: 2025-3-25 20:49
6樓
作者: 一加就噴出    時(shí)間: 2025-3-26 01:00
7樓
作者: Hamper    時(shí)間: 2025-3-26 07:25
7樓
作者: 袋鼠    時(shí)間: 2025-3-26 10:15
7樓
作者: 不透明性    時(shí)間: 2025-3-26 12:48
7樓
作者: tic-douloureux    時(shí)間: 2025-3-26 17:32
8樓
作者: amorphous    時(shí)間: 2025-3-26 23:04
8樓
作者: 格子架    時(shí)間: 2025-3-27 04:45
8樓
作者: 高談闊論    時(shí)間: 2025-3-27 07:40
8樓
作者: 放肆的你    時(shí)間: 2025-3-27 11:41
9樓
作者: conduct    時(shí)間: 2025-3-27 13:46
9樓
作者: 豐滿中國(guó)    時(shí)間: 2025-3-27 21:47
9樓
作者: 痛苦一生    時(shí)間: 2025-3-28 01:14
9樓
作者: Campaign    時(shí)間: 2025-3-28 03:26
10樓
作者: ANTI    時(shí)間: 2025-3-28 09:33
10樓
作者: 只有    時(shí)間: 2025-3-28 12:32
10樓
作者: 珠寶    時(shí)間: 2025-3-28 18:10
10樓




歡迎光臨 派博傳思國(guó)際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
婺源县| 博白县| 双城市| 深州市| 祁阳县| 江安县| 武穴市| 若羌县| 西华县| 灵台县| 赣榆县| 陆良县| 大丰市| 巨野县| 安康市| 顺平县| 潍坊市| 竹北市| 黑龙江省| 福安市| 贺兰县| 休宁县| 沈丘县| 三台县| 米泉市| 扎兰屯市| 高邮市| 永泰县| 神农架林区| 岳阳县| 清新县| 固原市| 墨竹工卡县| 建宁县| 姜堰市| 库伦旗| 普兰店市| 满洲里市| 甘孜| 丹棱县| 子长县|